Compile Data Set for Download or QSAR
Report error Found 946 for UniProtKB: P08648
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50139204(3-[4-(3-Guanidino-benzoylamino)-phenylsulfanyl]-3-...)
Affinity DataEC50: >1.00E+5nMAssay Description:K562 cell adhesion via integrin alpha5-beta1 to fibrinogenMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50021393(CHEMBL3289604)
Affinity DataEC50:  12nMAssay Description:Agonist activity at alpha5beta1 integrin in human K562 cells assessed as increase of fibronectin-mediated cell adhesion after 30 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50021394(CHEMBL3289605)
Affinity DataEC50:  763nMAssay Description:Agonist activity at alpha5beta1 integrin in human K562 cells assessed as increase of fibronectin-mediated cell adhesion after 30 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50021395(CHEMBL3289606)
Affinity DataEC50:  365nMAssay Description:Agonist activity at alpha5beta1 integrin in human K562 cells assessed as increase of fibronectin-mediated cell adhesion after 30 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50464108(CHEMBL4241824)
Affinity DataKd:  100nMAssay Description:Binding affinity to human integrin alpha5beta1 after 6 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50464108(CHEMBL4241824)
Affinity DataKd:  0.257nMAssay Description:Binding affinity to human integrin alpha8beta1 by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50464108(CHEMBL4241824)
Affinity DataKd:  0.260nMAssay Description:Binding affinity to human integrin alpha8beta1 by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50464108(CHEMBL4241824)
Affinity DataKd:  100nMAssay Description:Binding affinity to human integrin alpha5beta1 after 6 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50021395(CHEMBL3289606)
Affinity DataEC50:  365nMAssay Description:Agonist activity at alpha5beta1 integrin receptor in human K562 cells assessed as increase in fibronectin-induced cell adhesion pre-incubated for 30 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50505775(CHEMBL4442651)
Affinity DataEC50:  140nMAssay Description:Agonist activity at alpha5beta1 integrin receptor in human K562 cells assessed as increase in fibronectin-induced cell adhesion pre-incubated for 30 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50505779(CHEMBL4461771)
Affinity DataEC50:  1.03E+3nMAssay Description:Agonist activity at alpha5beta1 integrin receptor in human K562 cells assessed as increase in fibronectin-induced cell adhesion pre-incubated for 30 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50505782(CHEMBL4586928)
Affinity DataEC50:  9.90nMAssay Description:Agonist activity at alpha5beta1 integrin receptor in human K562 cells assessed as increase in fibronectin-induced cell adhesion pre-incubated for 30 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50021393(CHEMBL3289604)
Affinity DataEC50:  12nMAssay Description:Agonist activity at alpha5beta1 in human K562 cells assessed as increase in cell adhesion to fibronectin pre-incubated for 30 mins before fibronectin...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50021394(CHEMBL3289605)
Affinity DataEC50:  763nMAssay Description:Agonist activity at alpha5beta1 in human K562 cells assessed as increase in cell adhesion to fibronectin pre-incubated for 30 mins before fibronectin...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50021395(CHEMBL3289606)
Affinity DataEC50:  365nMAssay Description:Agonist activity at alpha5beta1 in human K562 cells assessed as increase in cell adhesion to fibronectin pre-incubated for 30 mins before fibronectin...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50550223(CHEMBL4794300)
Affinity DataEC50:  45nMAssay Description:Agonist activity at alpha5beta1 in human K562 cells assessed as increase in cell adhesion to fibronectin pre-incubated for 30 mins before fibronectin...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50550224(CHEMBL4797755)
Affinity DataEC50:  6.70nMAssay Description:Agonist activity at alpha5beta1 in human K562 cells assessed as increase in cell adhesion to fibronectin pre-incubated for 30 mins before fibronectin...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50505779(CHEMBL4461771)
Affinity DataEC50:  1.03E+3nMAssay Description:Agonist activity at alpha5beta1 in human K562 cells assessed as increase in cell adhesion to fibronectin pre-incubated for 30 mins before fibronectin...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50550228(CHEMBL4743438)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alpha5beta1 in human K562 cells assessed as increase in cell adhesion to fibronectin pre-incubated for 30 mins before fibronectin...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50505772(CHEMBL4589062)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alpha5beta1 in human K562 cells assessed as increase in cell adhesion to fibronectin pre-incubated for 30 mins before fibronectin...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50505782(CHEMBL4586928)
Affinity DataEC50:  9.90nMAssay Description:Agonist activity at alpha5beta1 in human K562 cells assessed as increase in cell adhesion to fibronectin pre-incubated for 30 mins before fibronectin...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50550225(CHEMBL4764510)
Affinity DataEC50:  49nMAssay Description:Agonist activity at alpha5beta1 in human K562 cells assessed as increase in cell adhesion to fibronectin pre-incubated for 30 mins before fibronectin...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50222360(Ac-Asp-Arg-Leu-Asp-Ser-OH | CHEMBL238484)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alpha5beta1 in human K562 cells assessed as increase in cell adhesion to fibronectin pre-incubated for 30 mins before fibronectin...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50313793((S)-3-(3-amino-4-(3-(5,6,7,8-tetrahydro-1,8-naphth...)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of human Integrin alpha5beta3 receptors expressed in HOP cells assessed as cell attachment after 30 mins by colorimetric assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-6/beta-8(Human)
Scifluor Life Sciences

US Patent
LigandPNGBDBM297773(US10118929, Compound A1)
Affinity DataIC50: 0.130nMAssay Description:The optimized protocol was validated by employing reference compounds such as Cilengitide (+Vβ3/αVβ5−VN interaction) and CWHM12 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50138318((5S,8S)-3-[(S)-2-Carboxy-2-(2,4,6-trimethyl-benzen...)
Affinity DataIC50: 0.180nMAssay Description:Inhibition of alpha5-beta1 integrin receptor in ELISAMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50138318((5S,8S)-3-[(S)-2-Carboxy-2-(2,4,6-trimethyl-benzen...)
Affinity DataIC50: 0.180nMAssay Description:Alpha-5 beta-1 antagonism using an ELISA assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-6(Human)
Saint Louis University

US Patent
LigandPNGBDBM279573((3S)-3-(3,5-dibromophenyl)-3-[[2-[[5-[(5-hydroxy-1...)
Affinity DataIC50: 0.200nMAssay Description:Recombinant human LAP (R&D Systems, 246-LP) diluted to 0.25 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM MgCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50313795((S)-3-(4-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2...)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of human Integrin alpha5beta3 receptors expressed in HOP cells assessed as cell attachment after 30 mins by colorimetric assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM279568((3S)-3-[3-bromo-5-(trifluoromethyl)phenyl]-3-[[2-[...)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:Purified human fibronectin (R&D Systems, 1918-FN) diluted to 2 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 m...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-6(Human)
Saint Louis University

US Patent
LigandPNGBDBM279561((3S)-3-(3-bromo-5-(trifluoromethyl)phenyl)-3-(2-(3...)
Affinity DataIC50: 0.300nMAssay Description:Recombinant human LAP (R&D Systems, 246-LP) diluted to 0.25 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM MgCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-6(Human)
Saint Louis University

US Patent
LigandPNGBDBM279566((3S)-3-[3-chloro-5-(trifluoromethyl)phenyl]3-[[2-[...)
Affinity DataIC50: 0.300nMAssay Description:Recombinant human LAP (R&D Systems, 246-LP) diluted to 0.25 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM MgCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
Saint Louis University

US Patent
LigandPNGBDBM279568((3S)-3-[3-bromo-5-(trifluoromethyl)phenyl]-3-[[2-[...)
Affinity DataIC50: 0.300nMAssay Description:Purified human fibronectin (R&D Systems, 1918-FN) diluted to 2 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 m...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-6(Human)
Saint Louis University

US Patent
LigandPNGBDBM279568((3S)-3-[3-bromo-5-(trifluoromethyl)phenyl]-3-[[2-[...)
Affinity DataIC50: 0.300nMAssay Description:Recombinant human LAP (R&D Systems, 246-LP) diluted to 0.25 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM MgCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-6(Human)
Saint Louis University

US Patent
LigandPNGBDBM279569((3S)-3-[3,5-bis(trifluoromethyl)phenyl)-3-(2-(3-hy...)
Affinity DataIC50: 0.300nMAssay Description:Recombinant human LAP (R&D Systems, 246-LP) diluted to 0.25 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM MgCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50138313((5S,8S)-8-[(1H-Benzoimidazol-2-ylamino)-methyl]-3-...)
Affinity DataIC50: 0.390nMAssay Description:Inhibition of alpha5-beta1 integrin receptor in ELISAMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50138313((5S,8S)-8-[(1H-Benzoimidazol-2-ylamino)-methyl]-3-...)
Affinity DataIC50: 0.390nMAssay Description:Alpha-5 beta-1 antagonism using an ELISA assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM50497721(CHEMBL3319235)
Affinity DataIC50: 0.390nMAssay Description:Antagonist activity at alpha5beta1 integrin receptor (unknown origin) by cell-free ELISAMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-6(Human)
Saint Louis University

US Patent
LigandPNGBDBM279560((3S)-3-(3,5-dibromophenyl)-3-(2-(3-hydroxy-5-((5-h...)
Affinity DataIC50: 0.400nMAssay Description:Recombinant human LAP (R&D Systems, 246-LP) diluted to 0.25 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM MgCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-6(Human)
Saint Louis University

US Patent
LigandPNGBDBM279562((3S)-3-[3-chloro-5-(difluoromethyl)phenyl)-3-(2-(3...)
Affinity DataIC50: 0.400nMAssay Description:Recombinant human LAP (R&D Systems, 246-LP) diluted to 0.25 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM MgCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-6(Human)
Saint Louis University

US Patent
LigandPNGBDBM279563((3S)-3-[3-bromo-5-(difluoromethyl)phenyl)-3-(2-(3-...)
Affinity DataIC50: 0.400nMAssay Description:Recombinant human LAP (R&D Systems, 246-LP) diluted to 0.25 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM MgCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-6(Human)
Saint Louis University

US Patent
LigandPNGBDBM279565((3S)-3-[3-bromo-5-chloro-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.400nMAssay Description:Recombinant human LAP (R&D Systems, 246-LP) diluted to 0.25 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM MgCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-6(Human)
Saint Louis University

US Patent
LigandPNGBDBM279567((3S)-3-(3-bromo-5-chloro-phenyl)-3-[[2-[[5-[(5-hyd...)
Affinity DataIC50: 0.400nMAssay Description:Recombinant human LAP (R&D Systems, 246-LP) diluted to 0.25 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM MgCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/alpha-V(Human)
Saint Louis University

US Patent
LigandPNGBDBM279570((3S)-3-[3-bromo-5-methyl-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.400nMAssay Description:Purified human fibronectin (R&D Systems, 1918-FN) diluted to 5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 m...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-6(Human)
Saint Louis University

US Patent
LigandPNGBDBM279572((3S)-3-[3-bromo-5-fluoro-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.400nMAssay Description:Recombinant human LAP (R&D Systems, 246-LP) diluted to 0.25 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM MgCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/alpha-8(Human)
Saint Louis University

US Patent
LigandPNGBDBM279573((3S)-3-(3,5-dibromophenyl)-3-[[2-[[5-[(5-hydroxy-1...)
Affinity DataIC50: 0.400nMAssay Description:Recombinant mouse nephronectin protein (R&D Systems, Inc, 4298-NP) diluted to 1 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM279562((3S)-3-[3-chloro-5-(difluoromethyl)phenyl)-3-(2-(3...)
Affinity DataIC50: 0.5nMpH: 7.4 T: 2°CAssay Description:Purified human fibronectin (R&D Systems, 1918-FN) diluted to 2 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 m...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1(Human)
Nerviano

Curated by ChEMBL
LigandPNGBDBM279570((3S)-3-[3-bromo-5-methyl-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.5nMpH: 7.4 T: 2°CAssay Description:Purified human fibronectin (R&D Systems, 1918-FN) diluted to 2 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 m...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
Saint Louis University

US Patent
LigandPNGBDBM279562((3S)-3-[3-chloro-5-(difluoromethyl)phenyl)-3-(2-(3...)
Affinity DataIC50: 0.5nMAssay Description:Purified human fibronectin (R&D Systems, 1918-FN) diluted to 2 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 m...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-6(Human)
Saint Louis University

US Patent
LigandPNGBDBM279564((3S)-3-[3-chloro-5-(trifluoromethyl)phenyl)-3-(2-(...)
Affinity DataIC50: 0.5nMAssay Description:Recombinant human LAP (R&D Systems, 246-LP) diluted to 0.25 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM MgCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 946 total ) | Next | Last >>
Jump to: